The audit plan was finalized after reviewing stakeholder comments received during a public feedback period.
The audit plan was finalized after reviewing stakeholder comments received during a public feedback period.
Agenda topics include topicals, GLP-1 drugs, biologics, PPI and H2 blockers, and more.
As part of the proposal, the state has issued a stakeholder survey that will close October 22nd.
The proposal would incorporate the latest ACOEM Guideline for knee disorders, and a public hearing is scheduled for October 16th.
According to the American Medical Association, the most highly educated naturopaths get only a fraction of the training that physicians receive.
The change aligns workers’ comp rules with a February 2026 court ruling on pharmacy choice.
The cap is for a 30-day supply. If actual acquisition cost exceeds $300, reimbursement would be limited to 120% of documented AAC.
Impacted items would include pharmacy and topical reimbursement, home health, prior authorization, and more.
Stakeholder feedback for the audit plan will be accepted until 5:00 PM CST on August 6th.
Recommendations from the California report touched on pharmacy topics and access to care.
The meeting discussed issues that could affect pharmacy reimbursement, statutory provider definitions, and medical accessibility reporting.
Commenters asked the DWC to clarify the scope of pharmacy and pharmacist definitions and prior authorization requirements.
The Fourth Edition of the AMA Guidelines have been in use since 2000 and would be updated to the Six Edition, published 2025.
The hearing will take place on July 15th, allowing interested stakeholders to attend virtually.
As part of proposed updates to the Healthcare Service rules and the state fee schedule, additional changes are up for debate.
